Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells

International Journal of Cancer

Volumn 104, Issue 1, 2003, Pages 1-6

  Hartwig, Andrea ^a   Pelzer, Anke ^a   Asmuss, Monika ^a,b   Bürkle, Alexander ^c  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Arsenic; Mammalian cells; PARP; Poly(ADP ribosyl)ation

Indexed keywords

ARSENIC TRIOXIDE; CLASTOGEN; DRINKING WATER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE);

ARTICLE; CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA MODIFICATION; ENZYME INHIBITION; EXCISION REPAIR; GENETIC STABILITY; HELA CELL; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MAMMAL CELL; POINT MUTATION; POLLUTANT; POLYRIBOSYLATION; PRIORITY JOURNAL; SKIN CANCER;

ARSENITES; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; GLYCOSYLATION; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; MUTAGENS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 0037430142     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10911     Document Type: Article

References (49)

1. IARC. Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 23: some metals and metallic compounds. Lyon: IARC, 1980.
2. National Research Council. Arsenic in drinking water. 2001 update. Washington, D.C.: National Academy of Sciences, 2001.
3. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin JS, Huang CH, Chen CJ. Incidence of internal cancers and ingested inorganic arsenic: a seven- year follow-up study in Taiwan. Cancer Res 1995;55:1296-300.
4. Gebel TW. Genotoxicity of arsenical compounds. Int J Hyg Environ Health 2001;203:249-62.
5. Basu A, Mahata J, Gupta S, Giri AK. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res 2001; 488:171-94.
6. Rossman TG. Enhancement of UV-mutagenesis by low concentrations of arsenite in E. coli. Mutat Res 1981;91:207-11.
7. Okui T, Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat Res 1986;172:69-76.
8. Snyder RD, Davis GF, Lachmann PJ. Inhibition by metals of X-ray and ultraviolet-induced DNA repair in human cells. Biol Trace Elem Res 1989;21:389-98.
9. Li JH, Rossman TG. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol Toxicol 1989;2:1-9.
10. Hartwig A, Gröblinghoff UD, Beyersmann D, Natarajan AT, Filon R, Mullenders LHF. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis 1997;18: 399-405.
11. Lee-Chen SF, Yu CT, Jan KY. Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis 1992;7: 51-5.
12. Hu Y, Su L, Snow ET. Arsenic toxicity is enzyme specific and its effects on ligation are not caused by the direct inhibition of DNA repair enzymes. Mutat Res 1998;408:203-18.
13. Mackay JP, Crossley M. Zinc fingers are sticking together. Trends Biochem Sci 1998;23:1-4.
14. O'Connor TR, Graves RJ, de Murcia G, Castaing B, Laval J. Fpg protein of Escherichia coli is a zinc finger protein whose cysteine residues have a structural and/or functional role. J Biol Chem 1993; 268:9063-70.
15. Miyamoto I, Miura N, Niwa H, Miyazaki J, Tanaka K. Mutational analysis of the structure and function of the xeroderma pigmentosum group A complementing protein. Identification of essential domains for nuclear localization and DNA excision repair. J Biol Chem 1992; 267:12182-7.
16. Asmuss M, Mullenders LHF, Eker A, Hartwig A. Differential effects of toxic metal compounds on the activities of Fpg and XPA, two zinc finger proteins involved in DNA repair. Carcinogenesis 2000;21: 2097-104.
17. de Murcia G, Shall S. From DNA damage and stress signalling to cell death. Oxford: Oxford University Press, 2000.
18. Bürkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays 2001;23:795-806.
19. Le Rhun Y, Kirkland JB, Shah GM. Cellular responses to DNA damage in the absence of Poly (ADP-ribose) polymerase. Biochem Biophys Res Commun 1998;245:1-10.
20. Althaus FR. Poly ADP-ribosylation: a histone shuttle mechanism in DNA excision repair. J Cell Sci 1992;102:663-70.
21. Pleschke JM, Kleczkowska HE, Strohm M, Althaus FR. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000;275:40974-80.
22. Ikejima M, Noguchi S, Yamashita R, Ogura T, Sugimura T, Gill DM, Miwa M. The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA. J Biol Chem 1990;265:21907-13.
23. Gradwohl G, Menissier de Murcia JM, Molinete M, Simonin F, Koken M, Hoeijmakers JH, de Murcia G. The second zinc-finger domain of poly (ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci USA 1990;87: 2990-4.
24. Yager JW, Wiencke JK. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat Res 1997;386:345-51.
25. Lynn S, Shiung JN, Gurr JR, Jan KY. Arsenite stimulates poly(ADP-ribosylation) by generation of nitric oxide. Free Radic Biol Med 1998;24:442-9.
26. Kawamitsu H, Hoshino H, Okada H, Miwa M, Momoi H, Sugimura T. Monoclonal antibodies to poly(adenosine diphosphate ribose) recognize different structures. Biochemistry 1984;23:3771-7.
27. Alvarez-Gonzalez R, Spring H, Muller M, Bürkle A. Selective loss of poly (ADP-ribose) and the 85-kDa fragment of poly (ADP-ribose) polymerase in nucleoli during alkylation-induced apoptosis of HeLa cells. J Biol Chem 1999;274:32122-6.
28. Küpper JH, de Murcia G, Bürkle A. Inhibition of poly(ADP-ribosy-1)ation by overexpressing the poly (ADP-ribose) polymerase DNA-binding domain in mammalian cells. J Biol Chem 1990;265:18721-4.
29. Bürkle A, Chen G, Küpper JH, Grube K, Zeller WJ. Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment. Carcinogenesis 1993;14:559-61.
30. Brochu G, Duchaine C, Thibeault L, Lagueux J, Shah GM, Poirier GG. Mode of action of poly(ADP-ribose) glycohydrolase. Biochim Biophys Acta 1994;1219:342-50.
31. Bürkle A, Meyer T, Hilz H, zur Hausen H. Enhancement of N-methyl-N′-nitro-N-nitrosoguanidine-induced DNA amplification in a simian virus 40-transformed Chinese hamster cell line by 3-aminobenzamide. Cancer Res 1987;47:3632-6.
32. Lynn S, Lai HT, Gurr JR, Jan KY. Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis 1997;12:353-8.
33. Li JH, Rossman TG. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol Toxicol 1989;2:1-9.
34. Lindahl T. Suppression of spontaneous mutagenesis in human cells 1 DNA base excision-repair. Mutat Res 2000;462:129-35.
35. Dantzer F, de La Rubia G, Menissier-De Murcia J, Hostomsky Z, de Murcia G, Schreiber V. Base excision repair is impaired in mammalian cells lacking Poly(ADP-ribose) polymerase-1. Biochemist 2000;39:7559-69.
36. Dantzer F, Schreiber V, Niedergang C, Trucco C, Flatter E, De La Rubia G, Oliver J, Rolli V, Menissier-de Murcia J, de Murcia G. Involvement of poly(ADP-ribose) polymerase in base excision repa Biochimie 1999;81:69-75.
37. Oei SL, Ziegler M. ATP for the DNA ligation step in base excision repair is generated from poly(ADP-ribose). J Biol Chem 2000;275: 23234-9.
38. Meyer R, Muller M, Beneke S, Küpper JH, Bürkle A. Negative regulation of alkylation-induced sister-chromatid exchange by poly(ADP-ribose) polymerase-1 activity. Int J Cancer 2000;88:351-5.
39. Bürkle A. Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett 2001; 163:1-5.
40. Jha AN, Noditi M, Nilsson R, Natarajan AT. Genotoxic effects of sodium arsenite on human cells. Mutat Res 1992;284:215-21.
41. Gonsebatt ME, Vega L, Salazar AM, Montero R, Guzman P, Blas J, Del Razo LM, Garcia-Vargas G, Albores A, Cebrian ME, Kelsh M, Ostrosky-Wegman P. Cytogenetic effects in human exposure to arsenic. Mutat Res 1997;386:219-28.
42. Gebel T, Christensen S, Dunkelberg H. Comparative and environmental genotoxicity of antimony and arsenic. Anticancer Res 1997;17: 2603-7.
43. Schaumlöffel N, Gebel T. Heterogeneity of the DNA damage provoked by antimony and arsenic. Mutagenesis 1998;13:281-6.
44. Yih LH, Lee TC. Arsenite induces p53 accumulation through an ATM-dependent pathway in human fibroblasts. Cancer Res 2000;60: 6346-52.
45. Menendez D, Mora G, Salazar AM, Ostrosky-Wegman P. ATM status confers sensitivity to arsenic cytotoxic effects. Mutagenesis 2001;16: 443-8.
46. Vogt BL, Rossman TG. Effects of arsenite on p53, p21 and cyclin D expression in normal human fibroblasts - a possible mechanism for arsenite's comutagenicity. Mutat Res 2001;478:159-68.
47. Hamadeh HK, Vargas M, Lee E, Menzel DB. Arsenic disrupts cellular levels of p53 and mdm2: a potential mechanism of carcinogenesis. Biochem Biophys Res Commun 1999;263:446-9.
48. Mass MJ, Wang L. Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis. Mutat Res 1997;386:263-77.
49. Knowles FC, Benson AA. The biochemistry of arsenic. Trends Biochem Sci 1983;8:178-80.